Detalles de la búsqueda
1.
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38876133
2.
Impacts of tumor microenvironment during neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.
Cancer Sci
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693726
3.
Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.
Esophagus
; 21(2): 102-110, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240916
4.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Esophagus
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38607538
5.
Influences of intratumoral heterogeneity on assessment of tumor microenvironment in esophageal squamous cell carcinoma.
Cancer Sci
; 114(3): 1180-1191, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36424361
6.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871043
7.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532830
8.
The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients.
Ann Surg Oncol
; 30(5): 2703-2712, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572808
9.
Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
BMC Cancer
; 23(1): 1051, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37915027
10.
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
BMC Cancer
; 23(1): 726, 2023 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543568
11.
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
BMC Cancer
; 23(1): 779, 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605122
12.
Survival Impacts of Impaired Lung Functions and Comorbidities on Elderly Esophageal Cancer Patients.
World J Surg
; 47(12): 3229-3239, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798404
13.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol
; 28(6): 756-763, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943545
14.
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab.
Int J Clin Oncol
; 28(9): 1139-1146, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37421478
15.
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Lancet
; 398(10302): 759-771, 2021 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34454674
16.
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
Invest New Drugs
; 40(3): 614-621, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278170
17.
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
BMC Cancer
; 22(1): 711, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35765021
18.
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Int J Colorectal Dis
; 37(6): 1393-1402, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585358
19.
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.
Int J Clin Oncol
; 27(12): 1805-1817, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264378
20.
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303).
Esophagus
; 19(4): 702-710, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904643